logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts | Conference Material / Video | MSF Science Portal
Conference Material
|Video

Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts

Lachenal N, Hewison CCH, Berry C, Mitnick CD, Ahmed SM, Osso E, Bastard M, Kazounis E, Motta I, Nyang'wa BT
Similar Content
Abstract
|Abstract
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 May 11 • MSF Scientific Days International 2022
Slide Presentation
|Slide Presentation
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 May 11 • MSF Scientific Days International 2022
Loading...

Countries

Kazakhstan Pakistan Uzbekistan

Subject Area

antibiotic resistancetuberculosiswomen's healthneonatal healthantimicrobial resistance

Languages

English
DOI
10.57740/mq3w-0280
Published Date
10 Jun 2022
Conference
MSF Scientific Days International 2022
Linked Content
Conference Material
|Abstract
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 May 11 • MSF Scientific Days International 2022
Conference Material
|Slide Presentation
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 May 11 • MSF Scientific Days International 2022